Alambic Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,707	Closed	-$442K	–	479
2017 Q4	$442K	Sell	6,707 -3,400	-34%	-$224K	0.05%	331
2017 Q3	$507K	Buy	10,107 +2,200	+28%	+$110K	0.06%	346
2017 Q2	$366K	Sell	7,907 -2,000	-20%	-$92.6K	0.04%	428
2017 Q1	$350K	Buy	+9,907	New	+$350K	0.04%	473